RASopathic Alopecia: Hair Changes Associated with Vemurafenib Therapy

    Bianca Maria Piraccini, Annalisa Patrizi, Píer Alessandro Fanti … Emi Dika
    Studysummary In this study, five out of six patients treated with vemurafenib for metastatic melanoma experienced hair loss, which improved after topical steroid treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. A Newly Discovered Linkage Between Proteoglycans and Hair Biology: Decorin Acts as an Anagen Inducer Experimental Dermatology · 2014

    Related research 5

    1. Bitemporal Scalp Hair Loss: Differential Diagnosis of Nonscarring and Scarring Conditions The Journal of clinical and aesthetic dermatology · 2021
    2. A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan Indian Journal of Dermatology · 2019
    3. Hair Loss in Children: Common and Uncommon Causes; Clinical and Epidemiological Study in Jordan International Journal of Trichology · 2013
    4. Diagnosis of Hair Loss: Clinical Features of Common Causes PubMed · 1992
    5. Diagnosis and Management of the Hair Loss Patient PubMed · 1987